The Seraseq® Triple X Syndrome (XXX) Reference Material is intended for use in Whole Genome or Targeted Next Generation Sequencing (NGS) assays, dPCR, or microarray assays that screen for Triple X Syndrome in cell-free fetal DNA (cfDNA). Seraseq® Triple X Syndrome (XXX) Reference Material is derived from DNA extracted from a pregnant patient source sample carrying a female fetus with confirmed Triple X Syndrome. Triple X Syndrome is also referred to as trisomy X, 47 or XXX. This product contains processed human cfDNA in a simulated plasma matrix, enabelling the assessing the complete workflow from extraction through to analysis, similar to clinical samples. This reference material is intended for researchers and Non-Invasive Prenatal Testing (NIPT) labs to monitor DNA extraction, library preparation, sequencing, and assay performance.